Jan 14 (Reuters) - Cyclopharm Ltd (CYC) :
- USFDA APPROVAL PROGRESS FOR TECHNEGAS AND BUSINESS UPDATE-CYC.AX
- TOTAL UNAUDITED REVENUE FOR 2020 WAS IN LINE WITH PRIOR YEAR AT A$14M
- US FDA APPROVAL TARGETED FOR Q2 ON TRACK WITH PRE‐APPROVAL AUDIT SCHEDULED FOR WEEK COMMENCING 29 MARCH 2021
- FAVOURABLE PROGRESS BEING MADE WITH REGARD TO LITIGATION PROCESS AGAINST FORMER EMPLOYEES
News: CYC Cyclopharm Says USFDA Approval Progress For Technegas
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
99.5¢ |
Change
-0.025(2.45%) |
Mkt cap ! $110.5M | |||
| Open | High | Low | Value | Volume |
| $1.01 | $1.03 | 99.0¢ | $207.2K | 207.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 9989 | 99.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.00 | 1000 | 1 |
View Market Depth
| Last trade - 16.10pm 16/06/2025 (20 minute delay) ? |
| CYC (ASX) Chart |